Introduction to Trasturel 150 mg Injection
Trasturel 150 mg Injection is a prescription medication used primarily in the treatment of HER2-positive breast cancer. It contains trastuzumab, a monoclonal antibody that specifically targets the HER2 receptor—a protein found in high amounts on the surface of certain cancer cells.
By binding to these receptors, Trasturel helps slow or stop the growth of cancer cells and may also help the immune system destroy them more effectively. This injection is typically given intravenously under the supervision of a qualified healthcare provider.
It may be used alone or in combination with other cancer treatments such as chemotherapy, depending on the stage and type of cancer being treated. Dosage and duration are carefully tailored based on the patient’s weight, medical condition, and response to treatment.
Uses of Trasturel 150 mg
Trasturel 150 mg is primarily used to treat cancers that overexpress the HER2 (Human Epidermal growth factor Receptor 2) protein. Its main uses include:
- HER2-Positive Breast Cancer
- HER2-Positive Metastatic Gastric (Stomach) Cancer
- HER2-Positive Esophagogastric Junction Cancer
How Does Trasturel 150 Works?
Trasturel 150 mg works by targeting the HER2 receptor, a protein found in large amounts on the surface of certain cancer cells. HER2 promotes the growth and division of these cells. Trasturel contains trastuzumab, a monoclonal antibody that binds specifically to the HER2 receptor, blocking its activity and preventing the cancer cells from receiving growth signals.
In addition to blocking the HER2 pathway, Trasturel also helps the immune system recognize and destroy cancer cells through a process called antibody-dependent cell-mediated cytotoxicity (ADCC). This dual action—blocking cell growth and activating the immune system—makes Trasturel an effective treatment for HER2-positive cancers.
Side Effects of Trasturel 150
- Fever or chills
- Nausea and vomiting
- Fatigue
- Diarrhea
- Headache
- Muscle or joint pain
- Skin rash
Dosage of Trasturel 150mg
The dosage of Trasturel 150 mg is tailored to each patient based on their body weight and the type of cancer being treated. It is usually given as an intravenous (IV) infusion, starting with a higher loading dose (typically 4 mg/kg), followed by a maintenance dose (usually 2 mg/kg weekly or 6 mg/kg every three weeks).
The exact schedule and amount depend on whether it’s used alone or with chemotherapy, and treatment continues until disease progression or unacceptable side effects occur.
Other Dosages of Trasturel
Warnings & Precautions
1. Heart Health:
- Trasturel can affect heart function and may cause heart failure or decrease in heart function. Patients with a history of heart disease or those at high risk for cardiac issues should be monitored closely. Baseline and periodic cardiac assessments are recommended to evaluate heart health before and during treatment.
2. Infusion Reactions:
- Infusion-related reactions, including severe allergic reactions, can occur. Patients should be monitored during the infusion process for signs of anaphylaxis or other serious reactions. Emergency measures and supportive treatments should be readily available if a severe reaction occurs.
3. Lung Function:
- There is a risk of interstitial lung disease (ILD) or pneumonitis, which can cause severe lung inflammation. Patients with pre-existing lung conditions or those experiencing respiratory symptoms should be closely monitored. Any new or worsening respiratory symptoms should be reported immediately.
4. Liver Function:
- Liver toxicity, including liver enzyme abnormalities and more severe liver damage, can occur. Regular liver function tests are necessary to detect any early signs of liver issues. Patients with liver impairment should be monitored more closely.
5. Infections:
- Trasturel can weaken the immune system, increasing the risk of serious infections. Patients should be vigilant for signs of infection, such as fever, chills, and other symptoms. Preventive measures and prompt treatment of infections are important to manage this risk.
6. Pregnancy and Breastfeeding:
- Trasturel is not recommended during pregnancy due to potential harm to the fetus. Effective contraception should be used during treatment. It is also not advised for breastfeeding mothers, as it may pass into breast milk and affect the infant.
7. Pre-existing Conditions:
- Patients with pre-existing conditions such as autoimmune diseases or severe gastrointestinal issues should inform their healthcare provider, as Trasturel may exacerbate these conditions or interact with other treatments.
Frequently Asked Questions
1. How is Trasturel administered?
Ans. It is given as an intravenous (IV) infusion by a healthcare professional, usually in a hospital or clinic setting.
2. Can I use Trasturel during pregnancy?
Ans. No, Trasturel is not recommended during pregnancy as it may harm the unborn baby. Effective birth control should be used during treatment and for several months afterward.
3. Can Trasturel 150mg Injection cure cancer?
Ans. The cure rate of cancer depends upon the severity of the disease. However, Trasturel 150mg Injection acts by preventing the abnormal growth and multiplication of cancer cells in the body, which may help in curing cancer completely.
4. Can the use of Trasturel 150mg Injection cause hair loss?
Ans. Hair loss is one of the common side effects of receiving Trasturel 150mg Injection. If it bothers you, consult your doctor for advice.
Reviews
There are no reviews yet.